Figure 2.
Prevalence of herpes zoster vaccination (1 May 2019–31 May 2022): 1 or 2 doses of recombinant zoster vaccine (Shingrix), as well as 1 dose of zoster vaccine live (Zostavax), by age and immunocompromised status.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.